rs199473482
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM5PP3_ModeratePP5
The NM_000218.3(KCNQ1):c.1748G>A(p.Arg583His) variant causes a missense change. The variant allele was found at a frequency of 0.0000279 in 1,613,672 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R583C) has been classified as Pathogenic.
Frequency
Consequence
NM_000218.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNQ1 | NM_000218.3 | c.1748G>A | p.Arg583His | missense_variant | 15/16 | ENST00000155840.12 | NP_000209.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCNQ1 | ENST00000155840.12 | c.1748G>A | p.Arg583His | missense_variant | 15/16 | 1 | NM_000218.3 | ENSP00000155840 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152174Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 251018Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135754
GnomAD4 exome AF: 0.0000274 AC: 40AN: 1461498Hom.: 0 Cov.: 32 AF XY: 0.0000371 AC XY: 27AN XY: 727064
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152174Hom.: 0 Cov.: 33 AF XY: 0.0000404 AC XY: 3AN XY: 74330
ClinVar
Submissions by phenotype
Long QT syndrome 1 Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Center For Human Genetics And Laboratory Diagnostics, Dr. Klein, Dr. Rost And Colleagues | Oct 29, 2021 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | KardioGenetik, Herz- und Diabeteszentrum NRW | May 06, 2024 | - - |
Cardiac arrhythmia Pathogenic:1Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | Feb 14, 2023 | This missense variant replaces arginine with histidine at codon 583 of the KCNQ1 protein. Computational prediction suggests that this variant may have deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). A functional study has shown that this variant does not cause severe functional impairment in transfected cells (PMID: 28749435). This variant has been reported in at least 4 unrelated individuals affected with long QT syndrome (15851171, 16414944, 18822425, 22456477, 24363352, 2460699, 26318259, 28749435, 32893267), in an individual affected with sudden unexpected death and epilepsy (PMID: 26423924), and in an individual suspected of having epilepsy (PMID: 31696929). This variant has been identified in 5/282380 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Aug 29, 2024 | Variant summary: KCNQ1 c.1748G>A (p.Arg583His) results in a non-conservative amino acid change located in the Potassium channel, voltage dependent, KCNQ, C-terminal domain (IPR013821) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 1.6e-05 in 251018 control chromosomes. c.1748G>A has been reported in the literature in multiple individuals affected with Arrhythmia and in two families, this variant has been shown to segregate with disease (Kanters_2004, Li_2024). These data indicate that the variant is very likely to be associated with disease. Two publications report experimental evidence evaluating an impact on protein function. While one experiment study shows that the variant results in impeded channel protein activation in the whole-cell patch-clamp assay and >70% reduction of forskolin-induced channel current (Li_2024), the other failed to find a signicifant effect of this variant on channel activity (Zullo_2017). The following publications have been ascertained in the context of this evaluation (PMID: 15851171, 38657442, 16414944, 34505893, 28749435). ClinVar contains an entry for this variant (Variation ID: 67053). Based on the evidence outlined above, the variant was classified as likely pathogenic. - |
Long QT syndrome Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | All of Us Research Program, National Institutes of Health | Dec 13, 2023 | This missense variant replaces arginine with histidine at codon 583 of the KCNQ1 protein. Computational prediction suggests that this variant may have deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). A functional study has shown that this variant does not cause severe functional impairment in transfected cells (PMID: 28749435). This variant has been reported in at least 4 unrelated individuals affected with long QT syndrome (15851171, 16414944, 18822425, 22456477, 24363352, 2460699, 26318259, 28749435, 32893267), in an individual affected with sudden unexpected death and epilepsy (PMID: 26423924), and in an individual suspected of having epilepsy (PMID: 31696929). This variant has been identified in 5/282380 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 09, 2022 | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 583 of the KCNQ1 protein (p.Arg583His). This variant is present in population databases (rs199473482, gnomAD 0.003%). This missense change has been observed in individual(s) with clinical features of long QT syndrome (PMID: 15851171, 16414944, 24363352, 28749435). ClinVar contains an entry for this variant (Variation ID: 67053). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). Experimental studies are conflicting or provide insufficient evidence to determine the effect of this variant on KCNQ1 function (PMID: 28749435). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jul 12, 2024 | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 15851171, 16414944, 28749435, 34505893, 22581653, 29021305, 24606995) - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 04, 2023 | The p.R583H variant (also known as c.1748G>A), located in coding exon 15 of the KCNQ1 gene, results from a G to A substitution at nucleotide position 1748. The arginine at codon 583 is replaced by histidine, an amino acid with highly similar properties. This variant has been detected in an individual with arrhythmia, a sudden unexplained death in epilepsy cohort, and long QT syndrome cohorts; however, in some cases, clinical detail was limited and additional variants in other arrhythmia-related genes were also detected. In addition, some reported cases may overlap (Kanters JK et al. Heart Rhythm, 2004 Sep;1:285-92; Christiansen M et al. BMC Med Genet, 2014 Mar;15:31; Napolitano C et al. JAMA, 2005 Dec;294:2975-80; Barsheshet A et al. Circulation, 2012 Apr;125:1988-96; Yoshinaga M et al. Circ Arrhythm Electrophysiol, 2014 Feb;7:107-12; Coll M et al. Int J Legal Med, 2016 Mar;130:331-9; Zullo A et al. Int J Mol Sci, 2017 Jul;18; Schwartz PJ et al. Eur Heart J, 2021 Dec;42:4743-4755). One functional study indicated this variant may impact some channel electrophysiological parameters, but not significantly impact current density; however, additional evidence is needed to confirm these findings (Zullo A et al. Int J Mol Sci, 2017 Jul;18). This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Congenital long QT syndrome Other:1
not provided, no classification provided | literature only | Cardiovascular Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust | - | This variant has been reported as associated with Long QT syndrome in the following publications (PMID:15851171;PMID:16414944). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at